Inhibitory 3-Domain KIR (but not IL28B) interact with inhibitory 2-Domain KIR in HCV-associated cirrhosis development in a VA hepatitis C cohort

Ryan, JC; Niemi, E; Shen, H; Segal, M; Lanier, LL; Monto, A

HEPATOLOGY, 2017; 66 ( ): 475A